Chapter 44: Drugs for the Treatment of Parasites

Drugs for the Treatment of Parasites academic overview explores the pharmacological strategies used to combat various parasitic infections, including those caused by protozoa, helminths, and ectoparasites. It defines parasitism as a biological relationship where one species thrives at the host's expense and details how antiparasitic drugs achieve selective toxicity to minimize host damage. The discussion on antiprotozoal therapy emphasizes the use of nitroimidazoles like metronidazole and tinidazole, which create cytotoxic free radicals in anaerobic environments to treat conditions like amebiasis, giardiasis, and trichomoniasis. A major portion of the text is dedicated to malaria, explaining the different stages of the Plasmodium lifecycle and the corresponding treatments; specifically, it contrasts primaquine's ability to clear dormant liver stages with the erythrocytic focus of chloroquine, quinine, and artemisinin derivatives. For helminth infections, the text examines how benzimidazoles like albendazole disrupt structural proteins and energy metabolism in roundworms, while ivermectin utilizes chloride channel modulation to paralyze nematodes. The treatment of flukes and tapeworms is primarily addressed through praziquantel, which uniquely enhances the host's immune response by altering the parasite's membrane permeability to calcium. Lastly, the chapter covers the management of ectoparasites like lice and mites, comparing traditional sodium channel inhibitors like permethrin to newer agents like spinosad and abametapir, which target nicotinic receptors or essential metalloproteinases to ensure the elimination of both adult parasites and their eggs.